Quick Links
Resources
About MyMyelomaTeam
Powered By
Overview
Astramorph is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat pain that is not responsive to non-narcotics. Astramorph may also be referred to by its drug name, morphine.… read more
Overview
Xpovio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have received at least four prior therapies. Xpovio is also… read more
Overview
Istodax is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cutaneous T-cell lymphoma in people who have already received at least one systemic therapy. Istodax is sometimes… read more
The Blenrep brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.
Overview
Blenrep is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat…
read moreOverview
Abecma is a therapy approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma after four or more prior therapies, including an immunomodulatory agent,… read more
Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma and non-Hodgkin lymphoma. Mozobil is also known by its drug name, plerixafor.
Mozobil is a… read more
Overview
Darzalex Faspro is approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma in adults. This treatment is used in combination with other drugs such as bortezomib, lenalidomide…
Overview
Tecvayli is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy. These… read more
Overview
Carvykti is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy.… read more
Overview
Talvey is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy. These…
Join